Starting a new anti‐seizure medication in drug‐resistant epilepsy: Add‐on or substitute?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Starting a new anti‐seizure medication in drug‐resistant epilepsy: Add‐on or substitute?

Published:2020-11-25 Issue:1 Volume:62 Page:228-237
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Janmohamed Mubeen¹²^ORCID,Lawn Nicholas¹,Spilsbury Katrina³,Chan Josephine¹,Dunne John¹⁴

Affiliation:

1. WA Adult Epilepsy Service Perth WA Australia

2. Central Clinical School Monash University Melbourne Vic. Australia

3. Institute for Health ResearchThe University of Notre Dame Australia Fremantle WA Australia

4. School of Medicine Royal Perth Hospital UnitUniversity of Western Australia Perth WA Australia

Funder

UCB Pharma

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/epi.16765

Reference34 articles.

1. Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs

2. Likelihood of seizure remission in an adult population with refractory epilepsy

3. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy

4. Treatment changes in a cohort of people with apparently drug-resistant epilepsy: an extended follow-up

5. Truly rational polytherapy: maximizing efficacy and minimizing drug interactions, drug load, and adverse effects;St Louis E;Curr Neuropharmacol,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Greater need for treatment optimization in patients with epilepsy initiating adjunctive therapy: Results of a retrospective claims analysis of antiseizure medication drug load in the United States;Epilepsy & Behavior;2024-03

2. Patterns of antiseizure medication utilization in the Human Epilepsy Project;Epilepsia;2023-10-27

3. The efficacy and safety of first-line anti-seizure medications as substitution therapy for children with drug-resistant epilepsy: a randomized controlled trial protocol;Frontiers in Neurology;2023-08-07

4. Focal Cortex Stimulation With a Novel Implantable Device and Antiseizure Outcomes in 2 Prospective Multicenter Single-Arm Trials;JAMA Neurology;2023-06-01

5. Should substitution monotherapy or combination therapy be used after failure of the first antiseizure medication? Observations from a 30‐year cohort study;Epilepsia;2023-03-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3